Cancer, Hematological Tumors, and Immuno-Oncology Solutions

Oncology, Hematology & Tumor Immunology

Unlocking the essence of disease through cellular intelligence to drive precision medicine and health management

Integrating multi-dimensional cell analysis with AI technology, we provide in-depth insights into the tumor microenvironment, immune status, and hematological diseases, facilitating precise diagnosis, treatment response prediction, and the development of personalized treatment strategies.

Clinical Challenges

Significant variation in treatment response

Patients respond differently to chemotherapy, targeted therapy, and immunotherapy, requiring more precise biomarker support.

High tumor heterogeneity

Even among patients with the same cancer type, there can be significant differences in their genetic characteristics, immune status, and treatment response.

High demand for disease and recurrence monitoring

Following cancer treatment, long-term monitoring of disease changes and recurrence risk remains essential to guide subsequent treatment decisions.

Complex tumor immune microenvironment

The interaction between tumor cells and immune cells affects disease progression and the efficacy of immunotherapy.

Key Assessment Areas

B Cell and Hematological Malignancy Analysis

Analyze B cell subsets, surface markers, immunoglobulin light chains, and monoclonal immunoglobulins to assist in the precise typing and diagnosis of hematological malignancies and B cell diseases.

Tumor Microenvironment Assessment

Integrate TAMs, MDSCs, CAFs, cytokines, and immune infiltration analysis to elucidate the tumor microenvironment and immune escape mechanisms.

Inflammatory Response Analysis

Through comprehensive monitoring of inflammation and damage markers, accurately identify the body's health risks, from acute warning signs to long-term chronic conditions.